| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8922532 | Clinical and Translational Radiation Oncology | 2016 | 6 Pages | 
Abstract
												For N0 patients treated with IMRT for HNSCC, waiting time around 50 days after the diagnosis was not significantly associated with an excessive risk of upstaging or recurrence.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Cédric Chevalier, Aurélie Bertaut, Magali Quivrin, Noémie Vulquin, Cédric Desandes, Mireille Folia, Christian Duvillard, Gilles Truc, Gilles Crehange, Philippe Maingon, 
											